NexImmune Announces Poster Presentation at the 2023 FOCIS Annual Meeting
<!-- Name:DistributionId Value:8844201 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
FOCIS
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS…
Proprietary, multi-specific NK cell engager platform, ANKET™, to generate next wave of immunotherapy moleculesANKET is first NK cell engager technology to engage NKp46, CD16, IL-2 variant…